OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity
Jaeoh Park, Pei‐Chun Hsueh, Zhiyu Li, et al.
Immunity (2023) Vol. 56, Iss. 1, pp. 32-42
Open Access | Times Cited: 155
Jaeoh Park, Pei‐Chun Hsueh, Zhiyu Li, et al.
Immunity (2023) Vol. 56, Iss. 1, pp. 32-42
Open Access | Times Cited: 155
Showing 26-50 of 155 citing articles:
Machine learning to establish three sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with gastric cancer
Jianing Yan, Xuan Yu, Qier Li, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Jianing Yan, Xuan Yu, Qier Li, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Guardians and Mediators of Metastasis: Exploring T Lymphocytes, Myeloid-Derived Suppressor Cells, and Tumor-Associated Macrophages in the Breast Cancer Microenvironment
Maria Rosaria Ruocco, Armando Gisonna, Vittoria Acampora, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6224-6224
Open Access | Times Cited: 4
Maria Rosaria Ruocco, Armando Gisonna, Vittoria Acampora, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6224-6224
Open Access | Times Cited: 4
An Immune‐Enhancing Injectable Hydrogel Loaded with Esketamine and DDP Promotes Painless Immunochemotherapy to Inhibit Breast Cancer Growth
Xiali Yin, Yaohua Ke, Ying Liang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 29
Open Access | Times Cited: 4
Xiali Yin, Yaohua Ke, Ying Liang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 29
Open Access | Times Cited: 4
Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies
Chang Zhu, J Liao, Yiyang Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Chang Zhu, J Liao, Yiyang Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
Junshu Li, Wencheng Zhou, Huiling Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 4
Junshu Li, Wencheng Zhou, Huiling Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 4
The transcription factor ZNF92 suppresses CD8( +) T cell viability and promotes malignant progression in lung adenocarcinoma by elevating PD-L1 expression
Xueqin Liu, Jinpeng Liu, Wei Wan, et al.
Molecular & Cellular Toxicology (2025)
Closed Access
Xueqin Liu, Jinpeng Liu, Wei Wan, et al.
Molecular & Cellular Toxicology (2025)
Closed Access
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Lower respiratory tract microbiome dysbiosis impairs clinical responses to immune checkpoint blockade in advanced non‐small‐cell lung cancer
Yong Zhang, Xiang‐Xiang Chen, Ruo Chen, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
Yong Zhang, Xiang‐Xiang Chen, Ruo Chen, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
Unveiling the role of MDH1 in breast cancer drug resistance through single-cell sequencing and schottenol intervention
Lü Jian, Feng Ding, Yongjie Sun, et al.
Cellular Signalling (2025), pp. 111608-111608
Closed Access
Lü Jian, Feng Ding, Yongjie Sun, et al.
Cellular Signalling (2025), pp. 111608-111608
Closed Access
Association between systemic immune-inflammation index and the risk of all-cause, cancer and non-cancer mortality in the general population: results from national health and nutrition examination survey 2005–2018
Siyu Wu, Zhao Liu, Xing Li, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Siyu Wu, Zhao Liu, Xing Li, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Identification of Anoikis-Related Genes in Chronic Kidney Disease Based on Bioinformatics Analysis Combined with Experimental Validation
Hong Liu, Manxue Mei, Hua Zhong, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 973-994
Open Access
Hong Liu, Manxue Mei, Hua Zhong, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 973-994
Open Access
CD4+CD8+ double-positive T cells in immune disorders and cancer: Prospects and hurdles in immunotherapy
Md Rakibul Alam, Amos Olalekan Akinyemi, Jianlin Wang, et al.
Autoimmunity Reviews (2025), pp. 103757-103757
Closed Access
Md Rakibul Alam, Amos Olalekan Akinyemi, Jianlin Wang, et al.
Autoimmunity Reviews (2025), pp. 103757-103757
Closed Access
Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
Xiang Wang, Wen Shen, Lan Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Xiang Wang, Wen Shen, Lan Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Crosstalk of SPINK4 Expression With Patient Mortality, Immunotherapy and Metastasis in Pan-Cancer Based on Integrated Multi-Omics Analyses
Xiuhua Cao, Na Luo, Xiaoyan Liu, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 161-177
Open Access
Xiuhua Cao, Na Luo, Xiaoyan Liu, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 161-177
Open Access
Exploring the co‐morbid relationship between Alzheimer's disease and lung cancer in the 5xFAD transgenic mouse model
Ming‐Feng Li, Xinghan Wu, Lin Jiang, et al.
Animal Models and Experimental Medicine (2025)
Open Access
Ming‐Feng Li, Xinghan Wu, Lin Jiang, et al.
Animal Models and Experimental Medicine (2025)
Open Access
Identification of the entosis-related prognostic signature and tumour microenvironment in hepatocellular carcinoma on the basis of bioinformatics analysis and experimental validation
Chen Wu, Shixu Fang, Liangliang Wu, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Chen Wu, Shixu Fang, Liangliang Wu, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration
Haibin Wang, Xinli Liu, Hesen Huang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Haibin Wang, Xinli Liu, Hesen Huang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Identification and multi-dimensional validation of mitochondrial permeability transition-driven necrosis-related model to assess the prognosis and immunotherapy value in breast cancer
Jinsong Liu, Wei Tong, Liuliu Quan, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Jinsong Liu, Wei Tong, Liuliu Quan, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Antigen-presenting fibroblasts: emerging players in immune modulation and therapeutic targets
Xiaoyun Chen, Fangqi Chen, Sujie Jia, et al.
Theranostics (2025) Vol. 15, Iss. 8, pp. 3332-3344
Open Access
Xiaoyun Chen, Fangqi Chen, Sujie Jia, et al.
Theranostics (2025) Vol. 15, Iss. 8, pp. 3332-3344
Open Access
Causal relationship between circulating immune cells and the risk of esophageal cancer: a Mendelian randomization study
Shangren Wang, Ruizhen Wang, Aiqiao Zhang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Shangren Wang, Ruizhen Wang, Aiqiao Zhang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Targeted delivery of CCL3 reprograms macrophage antigen presentation and enhances the efficacy of immune checkpoint blockade therapy in hepatocellular carcinoma
Muqi Liu, Linzhe Li, Lu Cao, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010947-e010947
Open Access
Muqi Liu, Linzhe Li, Lu Cao, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010947-e010947
Open Access
Ferroptosis in Pulmonary Disease and Lung Cancer: Molecular Mechanisms, Crosstalk Regulation, and Therapeutic Strategies
Dandan Guo, Songhua Cai, Lvdan Deng, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Dandan Guo, Songhua Cai, Lvdan Deng, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Interferon-driven Metabolic Reprogramming and Tumor Microenvironment Remodeling
Tzu-Hsuan Chang, Ping‐Chih Ho
Immune Network (2025) Vol. 25, Iss. 1
Open Access
Tzu-Hsuan Chang, Ping‐Chih Ho
Immune Network (2025) Vol. 25, Iss. 1
Open Access
Carrier-Free Nanocombo-Sensitized Photoimmunotherapy via Activation of α2-Adrenergic Receptors
Xiao-Kai Chi, Sihui Wang, Jingjing Gao, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Xiao-Kai Chi, Sihui Wang, Jingjing Gao, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
